XENOVA, the biotechnology company, was last month floated on the Nasdaq stock market in New York, and not on the New York Stock Exchange in our story about a new drug for cancer.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments